topotecan has been researched along with Rectal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Begg, AC; Bloom, G; Boulware, D; Calvin, DP; Eschrich, SA; Kelley, S; Lee, JH; Pramana, J; Rocha-Lima, C; Torres-Roca, JF; Yeatman, TJ; Zhang, H; Zhao, H | 1 |
1 trial(s) available for topotecan and Rectal Neoplasms
Article | Year |
---|---|
A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation.
Topics: Aged; Aged, 80 and over; Algorithms; Antineoplastic Agents; Cell Line, Tumor; Esophageal Neoplasms; Female; Gene Expression; Head and Neck Neoplasms; Humans; Linear Models; Male; Middle Aged; Models, Genetic; Oligonucleotide Array Sequence Analysis; Prognosis; Prospective Studies; Radiation Tolerance; Rectal Neoplasms; Topotecan | 2009 |